2Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease:meta-analysis of randomized trials. JAMA, 2005,294:819-825.
3Rodriguez AE, Mieres J, Fernandez-Pereira C, et al. Coronary stent thrombosis in the current drug-eluting stent era: insights form the ERACI Ⅲ trial. J Am Coll Cardiol, 2006,47:205-207.
4Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation, 2006,113:1108-1113.
5Bavry AA, Kumbhani DJ, Helton TJ, et al. What is the risk of stent thrombosis associated with the use of paclitaxel--eluting stents for percutaneous coronary intervention: a meta-analysis.J Am Coll Cardiol,2005 ,45 :941-946.
6Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors,and outcome of thrombosis after successful implantation of drugeluting stents.JAMA, 2005,293:2126-2130.
7Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymerbased paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.JAMA, 2005,294 : 1215-1223.
8Roiron C, Sanchez P, Bouzamondo A, et al. Drug eluting stents:an updated meta-analysis of randomised controlled trials. Heart,2006,92:641-649.
9Barry AA, Kumbhani DJ, Helton TJ, et al. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention : a meta-analysis.J Am Coll Cardiol,2005 ,45 :941-946.
10Ong AT, McFadden EP, Regar E,et al. Late angiographic stent thrombosis ( LAST ) events with drug-during stents.J Am Coll Cardiol,2005 ,45 :2088-2092.
